Fist Assist Devices FA-1 Compression Device to Be Distributed by Airos Medical in the United States

July 8, 2021—Fist Assist Devices, LLC, announced a 2-year affiliation with Airos Medical, Inc. to commercialize and launch sales of the Fist Assist FA-1 device in the United States. The Fist Assist FA-1 is a wearable intermittent compression device. On June 22, the company announced that the FA-1 received FDA clearance for arm vein massage and vein circulation.

Fist Assist Devices, which is based in Los Altos, California, is a privately held company founded by Chief Executive Officer Tej Singh, MD.

“We are thrilled to combine forces with Airos Medical for the official launch of the Fist Assist FA-1 device in the United States,” stated Dr. Singh in the company’s press release. “This is a huge milestone as we now have a committed, dedicated, and exceptional commercialization arm that is poised to deeply penetrate the United States market.”

Dr. Singh continued, “As a vascular surgeon, I have worked with pneumatic devices for lymphedema distributed by Airos for many years, and I am pleased to see Fist Assist join the Airos product line of innovative pneumatic products. I am very excited to finalize this alliance and look forward to working with Airos Medical to grow the United States market for the FA-1 device.”

Finally, he added, “Our goal at Fist Assist is to temporarily increase arm vein circulation and relieve minor muscle aches and soreness while making this innovative product available to as many users as possible. This alliance will help us achieve that.”

Airos is a medical technology manufacturer and designer that specializes in compression therapy for patients with lymphatic and venous disorders. Airos Medical was founded in 2016 and is headquartered in Audubon, Pennsylvania.

Chris Allerton, Vice President of Business Development of Airos commented in the announcement, “With the recent clearance for arm vein massage and vein circulation, we are excited to distribute and commercialize the innovative FA-1 device.”

Mr. Allerton further stated, “We have been watching the Fist Assist technology for the past 3 years and patiently awaiting market clearance as I believe this is a groundbreaking, market-changing, innovative, person-focused product that will improve user quality of life throughout the United States. Plus, as a pneumatic compression device, the FA-1 is a natural extension of our current product line and point of sale interaction. We are thrilled to be selected to launch and commercialize this technology.”